Cerebrospinal fluid lipoproteins in Alzheimer's disease

Casey Bassett, Kathleen S. Montine, M. Diana Neely, Larry L. Swift, Thomas J. Montine

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Interest in cerebrospinal fluid (CSF) lipoproteins has been stimulated by the association of certain alleles of the human apolipoprotein E gene (APOE) with an increased risk of Alzheimer's disease (AD), and because apolipoprotein E (apoE) is one of the major apolipoproteins in CSF. CSF lipoproteins (d < 1.210 g/ml fraction) are distinct from their plasma counterparts, and in AD patients CSF may contain novel particles. The protein concentration of CSF lipoproteins is reduced in AD patients. Moreover, the molecular distribution of apoE- and apoAII-containing apolipoproteins in CSF is dictated by APOE. The lipid composition suggests that CSF lipoproteins from AD patients may have undergone increased free radical-mediated damage; experimental data support the possibility that this may occur both before and after lipoprotein assembly. Finally, human CSF lipoproteins oxidized ex vivo are neurotoxic to neuronal cells in culture and disrupt microtubule structure, an activity not observed with oxidized bovine CSF lipoproteins. CSF lipoproteins may represent a means whereby apoE influences the outcome of free radical-mediated damage to brain. (C) 2000 Wiley-Liss. Inc.

Original languageEnglish (US)
Pages (from-to)282-286
Number of pages5
JournalMicroscopy Research and Technique
Volume50
Issue number4
DOIs
StatePublished - Aug 15 2000
Externally publishedYes

Fingerprint

cerebrospinal fluid
lipoproteins
Cerebrospinal fluid
Lipoproteins
Cerebrospinal Fluid
Alzheimer Disease
Apolipoproteins E
Apolipoproteins
Free Radicals
Free radicals
genes
free radicals
Genes
Cerebrospinal Fluid Proteins
damage
Microtubules
Lipids
brain
lipids
Cell Culture Techniques

Keywords

  • Alzheimer's disease
  • Apolipoproteins
  • Cerebrospinal flui

ASJC Scopus subject areas

  • Anatomy
  • Histology
  • Instrumentation
  • Medical Laboratory Technology

Cite this

Cerebrospinal fluid lipoproteins in Alzheimer's disease. / Bassett, Casey; Montine, Kathleen S.; Neely, M. Diana; Swift, Larry L.; Montine, Thomas J.

In: Microscopy Research and Technique, Vol. 50, No. 4, 15.08.2000, p. 282-286.

Research output: Contribution to journalReview article

Bassett, Casey ; Montine, Kathleen S. ; Neely, M. Diana ; Swift, Larry L. ; Montine, Thomas J. / Cerebrospinal fluid lipoproteins in Alzheimer's disease. In: Microscopy Research and Technique. 2000 ; Vol. 50, No. 4. pp. 282-286.
@article{ddd531c03a534053b7d5f08a19176bf7,
title = "Cerebrospinal fluid lipoproteins in Alzheimer's disease",
abstract = "Interest in cerebrospinal fluid (CSF) lipoproteins has been stimulated by the association of certain alleles of the human apolipoprotein E gene (APOE) with an increased risk of Alzheimer's disease (AD), and because apolipoprotein E (apoE) is one of the major apolipoproteins in CSF. CSF lipoproteins (d < 1.210 g/ml fraction) are distinct from their plasma counterparts, and in AD patients CSF may contain novel particles. The protein concentration of CSF lipoproteins is reduced in AD patients. Moreover, the molecular distribution of apoE- and apoAII-containing apolipoproteins in CSF is dictated by APOE. The lipid composition suggests that CSF lipoproteins from AD patients may have undergone increased free radical-mediated damage; experimental data support the possibility that this may occur both before and after lipoprotein assembly. Finally, human CSF lipoproteins oxidized ex vivo are neurotoxic to neuronal cells in culture and disrupt microtubule structure, an activity not observed with oxidized bovine CSF lipoproteins. CSF lipoproteins may represent a means whereby apoE influences the outcome of free radical-mediated damage to brain. (C) 2000 Wiley-Liss. Inc.",
keywords = "Alzheimer's disease, Apolipoproteins, Cerebrospinal flui",
author = "Casey Bassett and Montine, {Kathleen S.} and Neely, {M. Diana} and Swift, {Larry L.} and Montine, {Thomas J.}",
year = "2000",
month = "8",
day = "15",
doi = "10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T",
language = "English (US)",
volume = "50",
pages = "282--286",
journal = "Microscopy Research and Technique",
issn = "1059-910X",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Cerebrospinal fluid lipoproteins in Alzheimer's disease

AU - Bassett, Casey

AU - Montine, Kathleen S.

AU - Neely, M. Diana

AU - Swift, Larry L.

AU - Montine, Thomas J.

PY - 2000/8/15

Y1 - 2000/8/15

N2 - Interest in cerebrospinal fluid (CSF) lipoproteins has been stimulated by the association of certain alleles of the human apolipoprotein E gene (APOE) with an increased risk of Alzheimer's disease (AD), and because apolipoprotein E (apoE) is one of the major apolipoproteins in CSF. CSF lipoproteins (d < 1.210 g/ml fraction) are distinct from their plasma counterparts, and in AD patients CSF may contain novel particles. The protein concentration of CSF lipoproteins is reduced in AD patients. Moreover, the molecular distribution of apoE- and apoAII-containing apolipoproteins in CSF is dictated by APOE. The lipid composition suggests that CSF lipoproteins from AD patients may have undergone increased free radical-mediated damage; experimental data support the possibility that this may occur both before and after lipoprotein assembly. Finally, human CSF lipoproteins oxidized ex vivo are neurotoxic to neuronal cells in culture and disrupt microtubule structure, an activity not observed with oxidized bovine CSF lipoproteins. CSF lipoproteins may represent a means whereby apoE influences the outcome of free radical-mediated damage to brain. (C) 2000 Wiley-Liss. Inc.

AB - Interest in cerebrospinal fluid (CSF) lipoproteins has been stimulated by the association of certain alleles of the human apolipoprotein E gene (APOE) with an increased risk of Alzheimer's disease (AD), and because apolipoprotein E (apoE) is one of the major apolipoproteins in CSF. CSF lipoproteins (d < 1.210 g/ml fraction) are distinct from their plasma counterparts, and in AD patients CSF may contain novel particles. The protein concentration of CSF lipoproteins is reduced in AD patients. Moreover, the molecular distribution of apoE- and apoAII-containing apolipoproteins in CSF is dictated by APOE. The lipid composition suggests that CSF lipoproteins from AD patients may have undergone increased free radical-mediated damage; experimental data support the possibility that this may occur both before and after lipoprotein assembly. Finally, human CSF lipoproteins oxidized ex vivo are neurotoxic to neuronal cells in culture and disrupt microtubule structure, an activity not observed with oxidized bovine CSF lipoproteins. CSF lipoproteins may represent a means whereby apoE influences the outcome of free radical-mediated damage to brain. (C) 2000 Wiley-Liss. Inc.

KW - Alzheimer's disease

KW - Apolipoproteins

KW - Cerebrospinal flui

UR - http://www.scopus.com/inward/record.url?scp=0034663057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034663057&partnerID=8YFLogxK

U2 - 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T

DO - 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T

M3 - Review article

VL - 50

SP - 282

EP - 286

JO - Microscopy Research and Technique

JF - Microscopy Research and Technique

SN - 1059-910X

IS - 4

ER -